Zinc in PDB 6cvo: Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex
Enzymatic activity of Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex
All present enzymatic activity of Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex:
3.1.11.7;
3.1.12.2;
Protein crystallography data
The structure of Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex, PDB code: 6cvo
was solved by
M.J.Schellenberg,
P.P.Tumbale,
R.S.Williams,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.67 /
2.40
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
58.913,
72.547,
147.164,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.4 /
22.2
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex
(pdb code 6cvo). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex, PDB code: 6cvo:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 6cvo
Go back to
Zinc Binding Sites List in 6cvo
Zinc binding site 1 out
of 2 in the Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn402
b:29.0
occ:1.00
|
NE2
|
A:HIS335
|
2.0
|
29.3
|
1.0
|
NE2
|
A:HIS339
|
2.1
|
35.5
|
1.0
|
SG
|
A:CYS322
|
2.2
|
31.1
|
1.0
|
SG
|
A:CYS319
|
2.4
|
28.7
|
1.0
|
CE1
|
A:HIS335
|
2.9
|
32.0
|
1.0
|
H
|
A:CYS322
|
3.0
|
41.9
|
1.0
|
CD2
|
A:HIS335
|
3.0
|
27.0
|
1.0
|
CD2
|
A:HIS339
|
3.0
|
34.5
|
1.0
|
HB3
|
A:CYS322
|
3.1
|
40.3
|
1.0
|
CE1
|
A:HIS339
|
3.1
|
37.9
|
1.0
|
HE1
|
A:HIS335
|
3.1
|
38.5
|
1.0
|
HB3
|
A:CYS319
|
3.1
|
33.8
|
1.0
|
HD2
|
A:HIS339
|
3.2
|
41.3
|
1.0
|
CB
|
A:CYS322
|
3.2
|
33.6
|
1.0
|
HD2
|
A:HIS335
|
3.2
|
32.4
|
1.0
|
CB
|
A:CYS319
|
3.2
|
28.2
|
1.0
|
HE1
|
A:HIS339
|
3.3
|
45.5
|
1.0
|
HB2
|
A:CYS319
|
3.4
|
33.8
|
1.0
|
HB2
|
A:GLU321
|
3.5
|
44.1
|
1.0
|
N
|
A:CYS322
|
3.6
|
34.9
|
1.0
|
CA
|
A:CYS322
|
4.0
|
34.2
|
1.0
|
HB2
|
A:CYS322
|
4.0
|
40.3
|
1.0
|
ND1
|
A:HIS335
|
4.1
|
31.5
|
1.0
|
HB3
|
A:GLN324
|
4.1
|
43.8
|
1.0
|
H
|
A:GLN324
|
4.1
|
42.0
|
1.0
|
CG
|
A:HIS335
|
4.1
|
28.3
|
1.0
|
ND1
|
A:HIS339
|
4.2
|
39.2
|
1.0
|
CG
|
A:HIS339
|
4.2
|
37.8
|
1.0
|
H
|
A:GLU321
|
4.2
|
37.4
|
1.0
|
CB
|
A:GLU321
|
4.4
|
36.8
|
1.0
|
H
|
A:GLN323
|
4.5
|
43.4
|
1.0
|
C
|
A:GLU321
|
4.6
|
35.7
|
1.0
|
C
|
A:CYS322
|
4.6
|
34.1
|
1.0
|
HB2
|
A:GLN324
|
4.7
|
43.8
|
1.0
|
CA
|
A:CYS319
|
4.7
|
26.2
|
1.0
|
HB3
|
A:GLU321
|
4.7
|
44.1
|
1.0
|
HA
|
A:CYS322
|
4.8
|
41.1
|
1.0
|
N
|
A:GLN323
|
4.8
|
36.2
|
1.0
|
HD1
|
A:HIS335
|
4.8
|
37.8
|
1.0
|
CB
|
A:GLN324
|
4.8
|
36.5
|
1.0
|
HE3
|
A:LYS338
|
4.9
|
73.8
|
1.0
|
CA
|
A:GLU321
|
4.9
|
35.0
|
1.0
|
N
|
A:GLU321
|
4.9
|
31.1
|
1.0
|
HD23
|
A:LEU336
|
4.9
|
26.7
|
1.0
|
HD1
|
A:HIS339
|
4.9
|
47.1
|
1.0
|
N
|
A:GLN324
|
5.0
|
35.0
|
1.0
|
HD21
|
A:LEU326
|
5.0
|
31.4
|
1.0
|
|
Zinc binding site 2 out
of 2 in 6cvo
Go back to
Zinc Binding Sites List in 6cvo
Zinc binding site 2 out
of 2 in the Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Human Aprataxin (Aptx) Bound to Nicked Rna-Dna, Amp and Zn Product Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn402
b:24.0
occ:1.00
|
NE2
|
B:HIS339
|
2.0
|
35.4
|
1.0
|
NE2
|
B:HIS335
|
2.0
|
24.8
|
1.0
|
SG
|
B:CYS322
|
2.2
|
28.2
|
1.0
|
SG
|
B:CYS319
|
2.3
|
26.3
|
1.0
|
CE1
|
B:HIS339
|
2.7
|
27.3
|
1.0
|
HE1
|
B:HIS339
|
2.7
|
32.8
|
1.0
|
H
|
B:CYS322
|
2.9
|
34.1
|
1.0
|
CD2
|
B:HIS335
|
3.0
|
23.3
|
1.0
|
CE1
|
B:HIS335
|
3.0
|
26.7
|
1.0
|
HB3
|
B:CYS319
|
3.1
|
28.9
|
1.0
|
HB3
|
B:CYS322
|
3.1
|
35.8
|
1.0
|
HD2
|
B:HIS335
|
3.2
|
28.0
|
1.0
|
CB
|
B:CYS319
|
3.2
|
24.1
|
1.0
|
CD2
|
B:HIS339
|
3.2
|
31.7
|
1.0
|
HE1
|
B:HIS335
|
3.2
|
32.0
|
1.0
|
CB
|
B:CYS322
|
3.3
|
29.8
|
1.0
|
HB2
|
B:CYS319
|
3.3
|
28.9
|
1.0
|
HB2
|
B:GLU321
|
3.4
|
40.4
|
1.0
|
N
|
B:CYS322
|
3.6
|
28.5
|
1.0
|
HD2
|
B:HIS339
|
3.6
|
38.0
|
1.0
|
ND1
|
B:HIS339
|
3.9
|
27.9
|
1.0
|
CA
|
B:CYS322
|
4.0
|
28.8
|
1.0
|
HB2
|
B:CYS322
|
4.1
|
35.8
|
1.0
|
ND1
|
B:HIS335
|
4.1
|
26.5
|
1.0
|
HB3
|
B:GLN324
|
4.1
|
35.8
|
1.0
|
CG
|
B:HIS335
|
4.1
|
24.3
|
1.0
|
CG
|
B:HIS339
|
4.1
|
29.6
|
1.0
|
H
|
B:GLN324
|
4.1
|
33.3
|
1.0
|
H
|
B:GLU321
|
4.2
|
36.7
|
1.0
|
CB
|
B:GLU321
|
4.3
|
33.7
|
1.0
|
H
|
B:GLN323
|
4.5
|
30.7
|
1.0
|
C
|
B:GLU321
|
4.6
|
33.1
|
1.0
|
HD1
|
B:HIS339
|
4.6
|
33.5
|
1.0
|
CA
|
B:CYS319
|
4.6
|
28.0
|
1.0
|
HB3
|
B:GLU321
|
4.6
|
40.4
|
1.0
|
C
|
B:CYS322
|
4.7
|
27.2
|
1.0
|
HD23
|
B:LEU336
|
4.7
|
28.2
|
1.0
|
HB2
|
B:GLN324
|
4.7
|
35.8
|
1.0
|
HA
|
B:CYS322
|
4.8
|
34.6
|
1.0
|
N
|
B:GLN323
|
4.8
|
25.6
|
1.0
|
CA
|
B:GLU321
|
4.8
|
32.0
|
1.0
|
N
|
B:GLU321
|
4.8
|
30.6
|
1.0
|
CB
|
B:GLN324
|
4.8
|
29.8
|
1.0
|
HD1
|
B:HIS335
|
4.9
|
31.8
|
1.0
|
HA
|
B:CYS319
|
5.0
|
33.6
|
1.0
|
N
|
B:GLN324
|
5.0
|
27.8
|
1.0
|
|
Reference:
P.Tumbale,
M.J.Schellenberg,
G.A.Mueller,
E.Fairweather,
M.Watson,
J.N.Little,
J.Krahn,
I.Waddell,
R.E.London,
R.S.Williams.
Mechanism of Aptx Nicked Dna Sensing and Pleiotropic Inactivation in Neurodegenerative Disease. Embo J. V. 37 2018.
ISSN: ESSN 1460-2075
PubMed: 29934293
DOI: 10.15252/EMBJ.201798875
Page generated: Mon Oct 28 19:09:49 2024
|